phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma

$342,106P50FY2020CANIH

Northwestern University At Chicago, Evanston IL

Investigators

Maciej S Lesniakcontact

Linked publications & trials

Paper 39711568 Paper 39345374 Paper 39304717 Paper 39207859 Paper 39179895 Paper 39137048 Paper 39093629 Paper 39028616 Paper 38879494 Paper 38874796 Paper 38844770 Paper 38786045 Paper 38771655 Paper 38760638 Paper 38662454 Paper 38606301 Paper 38506351 Paper 38495570 Paper 38380331 Paper 38346200 Paper 38329732 Paper 38295144 Paper 38134929 Paper 38015629 Paper 37939133 Paper 37932003 Paper 37909335 Paper 37886538 Paper 37860079 Paper 37858339 Paper 37847564 Paper 37805627 Paper 37738539 Paper 37738033 Paper 37725593 Paper 37713675 Paper 37580817 Paper 37567247 Paper 37503127 Paper 37458855 Paper 37444568 Paper 37196077 Paper 37142373 Paper 37132598 Paper 37104042 Paper 37100086 Paper 37027168 Paper 36993741 Paper 36988488 Paper 36959214 Paper 36949040 Paper 36826993 Paper 36795563 Paper 36789150 Paper 36734195 Paper 36719372 Paper 36717738 Paper 36700952 Paper 36696444 Paper 36652630 Paper 36647828 Paper 36638329 Paper 36594466 Paper 36497370 Paper 36428586 Paper 36417993 Paper 36410047 Paper 36399711 Paper 36324813 Paper 36215167 Paper 36194889 Paper 36011015 Paper 35976058 Paper 35948282 Paper 35849553 Paper 35751573 Paper 35729337 Paper 35578106 Paper 35552677 Paper 35450486 Paper 35413115 Paper 35398250 Paper 35368609 Paper 35316217 Paper 35312341 Paper 35269518 Paper 35179776 Paper 35150865 Paper 35143189 Paper 35134075 Paper 35062028 Paper 35039931 Paper 34865083 Paper 34572775 Paper 34571905 Paper 34547202 Paper 34479957 Paper 34433651 Paper 34378243 Paper 34286581

View original record on NIH RePORTER →